Melanoma in the Fire Service - an Occupation We Need to Target for S…

Christine Kannler

Melanoma in Children

Riccardo Pampena

Overview of Skin Cancers for General Practitioners

Tarek Haykal

Spot That Diagnosis: Identifying Pigmented Lesions, Melanocytes, and…

LivDerm

F. Bellodi Schmidt

Lynch Syndrome and Skin: A Dermatologist’s Perspective

Dana-Farber Cancer Institute

V. Nambudiri

Role of Nivolumab/Relatlimab in the 1L Treatment Landscape for Metas…

Rodabe Amaria

Medical Treatments for Melanoma: Current and Future Options

Melanoma Research Foundation

F. Collichio

Optimal Therapy Sequence for 1L Treatment of BRAF-Mutated Metastatic…

Stanford Medicine

A. Betof Warner

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

Sun Safety and Melanoma Awareness: Expert Tips on Preventing Sun Dam…

Oncology Data Advisor

T. Knight, M. Hadfield

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

Jeff Yorio

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

2024 ESMO Annual Meeting Insights Hub

D. Johnson

AAD 2024 Insights: What's New In Nail Tumors

AAD Insights

J. Dominguez-Cherit

Efficacy of Nivo and Relatlimab as 1L Therapy for Metastatic Melanom…

Gabriela Cinat

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

Triumphs and Challenges in Treating Unresectable Melanoma

Melanoma Research Foundation

H. Kluger

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Melanoma Research Foundation

S. Chandra

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

Personalized Approaches to Treatment Selection in 1L Metastatic Mela…

Piotr Rutkowski